120 likes | 183 Views
Immuno-oncology is a unique approach that uses the bodys immune system to fight cancer. These therapies activate an individuals immune system, making it able to recognize cancer cells and destroy them. Immuno-oncology therapies provide long lasting anti-cancer benefits to patients who previously had very few treatment options available to them. These therapies work against a large number of cancer types.<br>
E N D
GLOBAL IMMUNO- ONCOLOGY MARKETREPORT MARKET RESEARCH REPORTS. www.jsbmarketresearch.com
REPORT SUMMARY A majority of the people you encounter on a day to day basis, out and about, at work or on your commute, The global immuno-oncology market has been segmented on the basis of type of product into monoclonal antibodies, therapeutic vaccines, and immune checkpoint inhibitors amongst others. According to the report, monoclonal antibodies segment was estimated to account for the largest share in 2016 due to rising prevalence ofcancer
DESCRIPTION GLOBAL IMMUNO- ONCOLOGY MARKET Amajorfocushasbeenontheongoing clinical trials for the development of innovativeproducts.Inthiscontext,the report provides information about the immuno-oncology programs at various stages of clinical development. In addition, the report highlights the strategic collaborations amongst the players for enhancing their market share.
According to the report Immuno-Oncology Market, By Type [mAb (Naked, Conjugate), Cancer Vaccines, Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4]), By Application (Lung, Melanoma, Leukemia, Lymphoma) - Global Forecast to 2022, the global immuno-oncology market is anticipated to cross US$ 100 Billion by 2022. The reportprovides a detailed analysis of the global immuno-oncology market. Thereport also provides the current and forecasted market forimmuno-oncology. US$100 BILLION BY2022
TABLE OF CONTENT GLOBAL IMMUNO-ONCOLOGY MARKET THERAPEUTIC VACCINES IMMUNO-ONCOLOGY MARKET, INDICATIONS GLOBAL BY MAJOR GLOBAL IMMUNO-ONCOLOGY MARKET TRENDS & DEVELOPMENTS COLLABORATIONS & ALLIANCES IN THE ONCOLOGY INDUSTRY STRATEGIC IMMUNO- COMPANY.COM
RELATED REPORTS Immuno-OncologyMarket,ByType[mAb(Naked,Conjugate),Cancer Vaccines, Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4]), By Application (Lung, Melanoma, Leukemia, Lymphoma) - Global Forecast to2022 GlobalPointofCareTestingMarket,byProduct (Glucometers,BGEAnalyzers,PregnancyTests, Infectious Diseases, etc.), Outlook2022
LIST OFTABLES Immuno-Onco l ogy - L a te S t a ge R e s e a r ch P i p e l i n e. US & E u r ope - M a jor D r ug Immuno-Onco l ogy P a t e nt E x p iry in M a r k et O n g o i ng T r i a ls for R i t u x an B r i s t ol M y e rs Sq u ibb- Key F i n a n ci a l s ( M i l l i on U S $ ), 201 4-201 6 N o v a r t is - Commercialized P r o d u c ts Immuno-Onco l ogy
ABOUTJSB MARKETRESEARCH The JSB Market Research Pvt. Ltd was foundedin2013,withitsmarketresearch report reseller’s portal www.jsbmarketresearch.com.We launched excellence in primary market researchreportstodedicatedlyassistour global clients by offering quick search service without any limitations to any industryverticals.
WE HOPE YOU CALL US THANKYOU WWW.JS BMARKETRESEARCH.COM